Systems and methods for adhering vessels

Information

  • Patent Grant
  • 12295645
  • Patent Number
    12,295,645
  • Date Filed
    Friday, June 29, 2018
    6 years ago
  • Date Issued
    Tuesday, May 13, 2025
    28 days ago
Abstract
Described here are devices, systems, and methods for adhering tubular structures, such as blood vessels. Generally, the methods may comprise advancing a first catheter comprising a first adhesion element into a first blood vessel and a second catheter comprising a second adhesion element into a second blood vessel. The vessels may be adhered together by heating tissue using the first and second adhesion elements.
Description
FIELD

The current invention relates to systems and methods for adhering tubular structures within the body, such as vessels.


BACKGROUND

The devices, systems, and methods described here may be used to enhance mechanical adhesion between tubular structures within the body. In some instances, this may be desirable to improve mechanical adhesion between tubular structures used to form fistulas. A fistula is generally a passageway formed between two internal organs. Forming a fistula between two tubular structures, such as blood vessels, can have one or more beneficial functions. For example, the formation of a fistula between an artery and a vein may provide access to the vasculature for hemodialysis patients. Specifically, forming a fistula between an artery and a vein allows blood to flow quickly between the vessels while bypassing the capillaries. In other instances, a fistula may be formed between two veins to form a veno-venous fistula. Generally, fistula formation requires surgical dissection of a target vein, and transecting and moving the vein for surgical anastomosis to the artery. It may therefore be useful to find improved ways to form a fistula between two blood vessels.


BRIEF SUMMARY

Described here are devices, systems, and methods for adhering two or more tubular structures together. The tubular structures may be any suitable tubular structure, such as an artery, vein, duct, digestive tract, and so forth. For example, the devices, systems, and methods disclosed herein may increase mechanical adhesion between two blood vessels such as an artery and a vein, a vein and a vein, an artery and an artery, or between a duct and a duct, a digestive tract and a digestive tract, and the like.


Generally, a method for adhering tubular structures described herein comprises advancing a first catheter into a first tubular structure and a second catheter into a second tubular structure. The first catheter may comprise a first adhesion element and the second catheter may comprise a second adhesion element. The first adhesion element may be aligned with the second adhesion element. The first and second tubular structures may be adhered by heating tissue between the two adhesion elements.


In some variations, a method of adhering vessels together comprises advancing a first catheter comprising a first magnetic adhesion element into a first blood vessel and a second catheter comprising a second magnetic adhesion element into a second blood vessel. The first magnetic adhesion element may be aligned with the second magnetic adhesion element. In some variations, the first magnetic adhesion element may be aligned with the second magnetic adhesion element by fluoroscopically visualizing at least a portion of the first and second catheters. In some variations, the first and/or second catheters may comprise one or more rotational indicators. The rotational indicators may be fluoroscopically visualized to align the catheters. Tissue of the first and second blood vessels may be compressed between the first and second magnetic adhesion elements. An adhesion (weld) may be formed between the first blood vessel to the second blood vessel by using the magnetic adhesion elements to heat tissue of the first and second blood vessels between the magnetic adhesion elements. In some variations, the tissue may be heated by delivery of radiofrequency energy from the magnetic adhesion elements. In other variations, the tissue may be heated by ohmic heating of the magnetic adhesion elements. In these variations the magnetic adhesion elements may comprise a resistor. Heating may occur over a single cycle, or a plurality of cycles. In some variations, impedance between the magnetic adhesion elements may be monitored before, after, or during energy delivery. Additionally or alternatively, tissue temperature may be monitored before, after, or during energy delivery. In some variations, a second adhesion may be formed between the first blood vessel and the second blood vessel. The formed adhesion(s) may in some instances have a width between about 0.1 mm and about 15 mm, and a length between about 0.1 mm and about 10 cm. In some variations, a fistula may be formed through the adhesion. For example, a fistula may be formed through the adhesion using the magnetic adhesion elements.


In some variations, a system for adhering two tubular structures together comprises a first catheter comprising a first adhesion element and a second catheter comprising a second adhesion element. The first adhesion element may be magnetic and may comprise a flat contact surface. The second adhesion element may be magnetic and comprise a flat contact surface. A power source may be connected to the first and second adhesion elements. In some variations, the first adhesion element may be located at a distal end of the first catheter, and the second adhesion element may be located at a distal end of the second catheter. The first and/or second adhesion elements may be coated with one or more layers of a fluoropolymer. Additionally or alternatively, the first and/or second magnetic adhesion elements may comprise surface insulation. In some variations, the first adhesion element may define a recess. In some of these variations, the second adhesion element may comprise a protrusion complementary to the recess. In some variations, the first and/or second catheter may comprise a rotational indicator.


In some variations, the first catheter may comprise a proximal portion and a distal portion, wherein the largest cross-sectional dimension of the distal portion is larger than the largest cross-sectional dimension of the proximal portion. The first adhesion element may be located on the distal portion. Additionally or alternatively, the second catheter may comprise a proximal portion and a distal portion, wherein the largest cross-sectional dimension of the distal portion is larger than the largest cross-sectional dimension of the proximal portion. The second adhesion element may be located on the distal portion. In some variations, at least one of the pushability, flexibility, or torquability of the first and/or second catheter may be adjustable. For example, the first catheter may comprise a distal portion, an inner proximal portion, and an outer proximal portion. The outer proximal portion may be slidable relative to the distal portion. The distal portion may have a retracted configuration and an extended configuration. The distal portion may be configured to extend away from the outer proximal portion when moved from the retracted configuration to the extended configuration.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a block diagram of an illustrative variation of a system.



FIGS. 2A-2D are views of an illustrative system described here in vasculature.



FIGS. 3-4 are perspective views of a distal portion of an illustrative variation of a catheter comprising an adhesion element described here.



FIGS. 5A-5F are perspective views of variations of adhesion elements.



FIGS. 6A-6C are cross-sectional side views of variations of adhesion elements.



FIGS. 7-8 are perspective views of distal portions of variations of catheters comprising adhesion elements described here.



FIGS. 9A-9E are side views (FIGS. 9A, 9B, 9D) and perspective views (FIGS. 9C, 9E) of distal portions of a catheter in retracted (FIGS. 9A-9C) and extended (FIGS. 9D-9E) configurations.



FIG. 10 is a perspective view of an illustrative variation of a distal portion of a catheter comprising a separate magnet and adhesion element.



FIGS. 11A-11B are perspective views of an illustrative variation of a system described here.



FIGS. 12A-12B are cross-sectional and plan views, respectively, of adhered vessels.



FIGS. 13A-13B are cross-sectional and plan views of a vessel comprising a weld and a fistula.





DETAILED DESCRIPTION

Generally described here are devices, systems, and methods for increasing mechanical adhesion between tubular structures, such as blood vessels, and in some instances forming a weld between the structures to adhere the two structures together. Generally, to adhere two tubular structures together, a system comprising multiple catheters may be advanced in a minimally invasive fashion (e.g., for blood vessels, via the vasculature) to a target location and used to adhere the tubular structures together. In some examples, the tubular structures may comprise blood vessels such as two arteries, two veins, or a vein and an artery.


Generally, each catheter may comprise an adhesion element. An adhesion element may comprise an element capable of adhering tissue, either alone or in combination with another adhesion element. An adhesion element may be configured to adhere tissue together by heating the tissue. In some variations, an adhesion element may heat issue by delivering electrical energy to the tissue. In some of these variations, the adhesion element may comprise a magnet configured to heat tissue by delivering electrical current, as described in more detail herein. In other variations, an adhesion element may be heated through resistive heating, which may in turn heat tissue. In yet other variations, an adhesion element may heat tissue using laser energy. For example, a catheter may comprise a fiber optic filament coupled to a laser, such that the adhesion element may be configured to direct laser energy to heat tissue. In yet another variation, an adhesion element may deliver ultrasonic energy to heat tissue. In such a variation, the adhesion element may comprise a piezoelectric element configured to use ultrasonic vibration to induce heating.


A first catheter comprising an adhesion element may be placed at a target location in a first tubular structure, and a second catheter comprising an adhesion element may be placed at a target location in a second tubular structure. The catheters may be aligned relative to each other using the adhesion elements, coaption regions, and/or visual alignment aids, as described in more detail herein. For example, when the tubular structures are blood vessels, a first catheter may be placed in a first blood vessel, and a second catheter may be placed in a second blood vessel, where the first and second vessels are in proximity to each other, and the two catheters may be aligned to coapt the two vessels. Tissue heating due to one or more adhesion elements may adhere tissue of the first tubular structure to tissue of the second tubular structure. For example, current applied to blood vessel walls may denature proteins in each vessel, which may cause them to adhere together. Adhesion may be performed before, during, or after other procedures, such as fistula formation, as described in more detail herein.


I. Systems


Generally, the systems described here are configured to adhere tubular structures in the body, such as blood vessels. In some variations, the systems comprise two catheters each comprising one or more adhesion elements. An adhesion element may comprise an element capable of adhering tissue, either alone or in combination with another adhesion element, and may be configured to adhere tissue together by heating the tissue. In some variations, an adhesion element may heat issue by delivering electrical current to the tissue, while in other variations an adhesion element may heat tissue by delivering laser or ultrasonic energy to the tissue. In yet other variations, an adhesion element may be resistively heated, which may in turn heat tissue. In some variations, an adhesion element may comprise a magnet configured to deliver energy to tissue, although in other variations it may comprise a non-magnetic element.


The adhesion elements may be configured to be delivered to target locations in tubular structures (e.g., blood vessels) via catheters. When an adhesion element is configured to heat tissue by delivering electrical energy, it may comprise a contact surface configured to contact tissue (e.g., a blood vessel wall) or fluid (e.g., blood). When the contact surface is in contact with tissue and/or fluid at the target location, it may supply current to and/or carry current from the tissue and/or fluid. This may result in heat, which in turn may facilitate adhesion of one portion of tissue to another. More particularly, current applied to the adhesion elements may be configured to heat and/or desiccate tissue to mechanically adhere the vessels together through protein denaturation. In some instances, tissue may be thermally welded together by applying a coagulation current to an electrode to denature connective tissue proteins and thereby increase adhesion between tissue planes. In some instances, the denatured proteins from each vessel may intertwine to fuse together and/or shrink the vessel. In some variations, thermal denaturing and welding may modify the vessel without removing material as occurs when ablating tissue.



FIG. 1 is a block diagram of one variation of a system comprising a first catheter (100) and a second catheter (104). The first catheter (100) may comprise a first adhesion element (102) and the second catheter (104) may comprise a second adhesion element (106). At least a portion of the adhesion elements may be exposed to the surrounding environment (i.e., may not be fully encompassed by the catheters). The adhesion elements (102, 106) may comprise electrically conductive magnets, as described in more detail herein, although they need not be magnetic. In use, the first catheter (100) and the second catheter (104) may be placed in first and second tubular structures (e.g., blood vessels), respectively, wherein the tubular structures are adjacent, and the adhesion elements (102, 106) may interact to adhere the outer wall of the first structure (e.g., blood vessel) to the outer wall of the second structure (e.g., blood vessel). In some variations, the adhesion elements may adhere the tissue by delivering electrical energy to the tissue. As such, a proximal end of each catheter (100, 104) may be connected to a power supply (110) by respective connections (108). The power supply (110) may further comprise a controller (not shown) for controlling energy delivery to the catheters (100, 104). The power supply (110) may be an AC or DC power supply. The power supply (110) may output current to heat and/or desiccate tissue.


In some variations, the adhesion elements (102, 106) may each deliver electrical energy to heat tissue. For example, each adhesion elements (102, 106) may be connected to an active output of the power supply (110) to deliver current and thus heat adjacent tissue. As such, the adhesion elements (102, 106) may simultaneously heat tissue from opposing sides. A ground pad (e.g., a large metal plate or flexible metalized pad) affixed to the patient may be connected to a return terminal of the power supply. In other variations, the first adhesion element (102) may be connected to the active output of the power supply (110) and the second adhesion element (106) may be connected to the return terminal. In yet other variations, the first adhesion element (102) may be connected to an output of the power supply, and the second adhesion element (106) may be floating, that is, not directly connected to any output of the power supply, in a focused monopolar configuration.


It should be appreciated that in other variations, only the first catheter may be connected to the power supply in a monopolar configuration. For example, only the first adhesion element may heat tissue, while the second adhesion element may mechanically contribute to tissue adhesion by pressing tissue toward the first adhesion element while the first adhesion element heats tissue. In such a configuration, the first adhesion element may be connected to an active output of a power supply, and a ground pad affixed to the patient may be connected to a return terminal of the power supply. The second adhesion element may not be connected to the power supply but may oppose the first adhesion element and compress tissue between the two adhesion elements, promoting heating and adhesion.


The catheters and adhesion elements may be configured to coapt with each other and to compress tissue between the adhesion elements in order to adhere tissue when it is heated. In some instances, a system may comprise first and second catheters each having one or more magnets, such that magnets of the first catheter may be attracted to magnets of the second catheter to bring the catheters in closer approximation. In some variations, the adhesion elements themselves may be magnets and may be configured to be attracted to each other. As such, the adhesion elements may promote axial and/or rotational alignment of the catheters. Additionally or alternatively, the catheters may comprise coaption regions comprising magnets, and/or may comprise one or more visual alignment aids, to promote tissue coaption as well as axial and/or rotational alignment of the catheters. For instance, a rotational indicator may allow catheter alignment to be visualized under fluoroscopy, such that a user may manipulate the catheters into a desired position. In some variations, the catheters may also be configured to promote the ability of an adhesion element to press into tissue, as described in more detail herein. The catheters may have the same configuration of elements, or may have different and/or complementary configurations of elements.



FIGS. 2A-2C show an exemplary system comprising two catheters each comprising an adhesion element comprising a magnet. A first catheter (200) comprising an adhesion element (202) is shown located within a first blood vessel (204). A second catheter (206) comprising an adhesion element (208) is shown located within a second blood vessel (210). The shape and material of the adhesion elements may help to align one catheter in a first vessel with another catheter in a second vessel, and may help to ensure optimal heating and adhesion. In the variation shown in FIGS. 2A-2D, each of the adhesion elements (202, 208) comprises a rectangular magnet. The adhesion elements (202, 208) may be configured to be attracted to each other when in proper axial and rotational alignment. FIGS. 2A-2B show the catheters (200, 206) placed in the vessels without coaption due to magnetic attraction, while FIGS. 2C-2D show the catheters coapted due to magnetic attraction between the adhesion elements (202, 208). When the catheters are coapted as in FIGS. 2C-2D, the walls of vessels (204, 210) may be compressed between the two adhesion elements (202, 208). That is, during alignment of the catheters (200, 206), the attractive magnetic forces of the adhesion elements (202, 208) may bring the catheters (200, 206) and blood vessels (204, 210) into closer approximation, as shown in FIGS. 2C-2D. This compression may aid with heating and adhesion. Each of the adhesion elements (202, 208) may comprise a flat contact surface configured to be contact with the interior vessel wall when the catheters are coapted across the vessel walls.


The adhesion elements (202, 208) may comprise a conductive material and may be connected to a power supply configured to provide electrical current for heating tissue. FIG. 3 is a perspective view of a distal end of the catheter (200) and the adhesion element (202), shown with a portion of the adhesion element cut away to depict the interior of the adhesion element. As described above, the adhesion element (202) shown may be a magnet that may coapt with another magnet of another catheter (e.g., adhesion element (208) of catheter (206)) to compress tissue therebetween. The adhesion element (202) may comprise one or more flat contact surfaces (214) for providing flush contact with tissue to be heated. Furthermore, in addition to bringing the catheters closer together and compressing tissue, a flat contact surface, such as contact surface (214), may allow a lateral magnetic coaption force to be generated and translated into an aligning torque, which may aid rotational alignment, as well as axial alignment, with an adhesion element of a second catheter. A wire (212) may be located within the catheter (200) and may electrically couple the adhesion element (202) to a power source such as an external power supply. This may allow an external power supply to energize the adhesion element (202). For example, returning to FIGS. 2A-2D, once the adhesion elements (202, 208) are coapted at a desired location, one or more of the adhesion elements may be energized to apply heat to the vessels (204, 210). The heat applied to the compressed vessel tissue (204, 210) may denature proteins in a manner to adhere the vessels together and may form a weld, which may increase the mechanical strength of the vessels. Upon completion of welding between the blood vessels (204, 210), the catheters (200, 206) may be removed.


When heat is applied to the compressed vessels using the devices, systems, and methods described herein, heating tissue to 70° C. may result in denaturation. In some variations, the delivered energy may be constant, while in other variations it may be modulated. In some variations, the tissue may be heated by the delivery of radiofrequency energy to tissue. The power source may deliver energy having any suitable waveform to the tissue via the adhesion elements, such as but not limited to waveform having a sinusoidal or square shape. Electrical energy delivered to tissue may have a peak voltage below the ionization threshold of the tissue. For example, when the waveform is a sinusoidal waveform, the peak voltage may in some variations be below about 150 V. It should also be appreciated that in other variations, current need not travel through tissue in order to heat the tissue. For example, the tissue may be heated through ohmic heating of the adhesion elements. For example, each adhesion element may comprise a resistor resulting in ohmic heating. In these instances, either AC or DC current may be used. In yet other variations, the tissue may be heated through laser or ultrasonic energy delivery.


In some variations, one or more surfaces of an adhesion element may be coated with a material that may facilitate removal of the adhesion element from a tissue surface after heating. For example, one or more surfaces of an adhesion element may be coated with one or more layers of PTFE, parylene, silicone, or another fluoropolymer. FIG. 4 is a perspective view of another variation of a catheter (400) comprising an adhesion element (402) comprising a rectangular magnet, and a wire (404) extending through the catheter (400) to electrically couple to the adhesion element (402) to a power supply. A surface of the adhesion element (402) may comprise a coating (406), wherein the coating comprises a material that may facilitate the removal of the adhesion element (402) from a tissue surface without sticking. For example, the coating (406) may comprise one or more layers of PTFE, parylene, silicone, or another fluoropolymer. In some variations, the coating (406) may additionally or alternatively comprise a jacket of material for enhanced biocompatibility or electrical conductivity, such as one or more of gold, platinum, and titanium. In some variations, the adhesion element (402) may be additionally or alternatively partially coated with an insulative coating in order to insulate certain surfaces and leave other surfaces exposed for electrical conduction to the tissue. This may direct and/or isolate energy delivery to a specific region of tissue and/or in a specific shape.


Generally, catheters in the coapted state, as shown in FIGS. 2C-2D for example, may sandwich the tissue interposed between their surfaces with a desired pressure as determined by the size, shape, and material composition of the adhesion elements. Adhesion elements having a flat contact surface, as shown in FIGS. 2A-4 for example, may promote rotational alignment and may better compress tissue for adhesion. These flat surfaces may help to naturally align the adhesion elements with each other, as two flat surfaces may generate a greater aligning torque for a given amount of rotational misalignment than two curved surfaces. For example, in some instances, the aligning torque generated between flat magnetic surfaces at 5 degrees of misalignment is at least approximately 18 times stronger than that of the aligning torque between magnetic cylinders.



FIGS. 5A-5E show a variety of possible shapes for adhesion elements, each comprising a flat contact surface. For example, an adhesion element (500) may have a square cross-section (FIG. 5A); an adhesion element (502) may have a triangular cross-section (FIG. 5B); an adhesion element (504) may have a hexagonal cross-section (FIG. 5C); an adhesion element (506) may have an a rectangular cross-section (FIG. 5D); an adhesion element (508) may have a semi-circular cross-section (FIG. 5E), or the like to provide a flat contact surface for an adhesion element.


However, in other variations, the adhesion elements may not comprise flat contact surfaces. For example, FIG. 5F illustrates an adhesion element (510) having a circular cross-section. As another example, FIGS. 6A-6B illustrate cross-sectional views of two adhesion element pairs, where one adhesion element is configured to be located in a first tubular structure (e.g., a blood vessel), and a second adhesion element is configured to be located in a second tubular structure (e.g., a second blood vessel). The adhesion elements shown there may comprise one or more protrusions and recesses, where the protrusions and recesses may be complementary. These protrusions and recesses may form an indent in tissue interposed between the adhesion elements. Pairs of adhesion elements having complementary shapes, as shown in FIGS. 6A-6B, may allow greater pressure to be applied to tissue between the two adhesion elements. In some variations, the protrusions (608, 610) may have the shape of a block (see adhesion element (600) in FIG. 6A) or a rigid fin (see adhesion element (604) in FIG. 6B) or point. The recesses (612, 614) of adhesion elements (602, 606) may have complementary shapes to the protrusions (608, 610). In other variations, a pair of adhesion elements may have the same shape. For example, FIG. 6C illustrates a cross-sectional view of a pair of matching adhesion elements (616, 618), each having a raised perimeter and a recessed central region (620, 622). A similar adhesion element having a raised rectangular perimeter and a recessed central region is shown in FIG. 8, described in more detail herein. In some variations, the protruding member may have a hollow interior for decreasing the surface area of the protruding member so that a first current may be applied to adhere tissue and a second current may be supplied to cut an opening through the tissue.


The adhesion elements described herein may be attached to catheters, as shown for example in FIGS. 2A-2D. Generally, the systems may comprise a first catheter for placement in a first tubular structure (e.g., a blood vessel) and a second catheter for placement in a second tubular structure (e.g., a blood vessel), where each catheter may comprise at least one adhesion element. The catheters may have any suitable diameter. For intravascular use, for example, the catheters may be about 4 French, about 5.7 French, about 6.1 French, about 7 French, about 8.3 French, between about 4 French and about 9 French, between about 4 French and about 7 French, between about 4 French and about 6 French, or the like. In the variation shown in FIGS. 2A-2D, the widest dimension of the adhesion elements (202, 208) is greater than the diameter of the catheters (200, 206). This may allow the contact surfaces of the adhesion elements (202, 208) to more easily contact tissue.


In other variations, the catheters described herein may be configured to promote the ability of an adhesion element to press into tissue. For example, the adhesion element may be located on a portion of a catheter having a greater diameter than an adjacent portion of a catheter. This may allow the contact surfaces of the adhesion elements to more easily contact tissue. For example, FIG. 7 is a perspective view of a variation of a catheter (700) having an adhesion element (706) embedded within a portion of the catheter and having an exposed flat contact surface. Catheter (700) comprises a proximal portion (702), a distal portion (704), and an adhesion element (706) disposed on the distal portion (704) and having a flat contact surface. As shown, the largest cross-sectional dimension of the distal portion (704) comprising the adhesion element (706) is larger than the largest cross-sectional dimension of the proximal portion (702) of the catheter. As such, the adhesion element (706) may be able to press into tissue without obstruction from contact between the proximal portion (702) of the catheter (700) and tissue, for example, a vessel wall. FIG. 8 illustrates another catheter (800) comprising a proximal portion (802) and a distal portion (804), where the distal portion (804) has a larger cross-sectional dimension than the proximal portion (802). The catheter (800) further comprises an adhesion element (806) disposed on the distal portion (804), where the adhesion element (806) comprises a raised perimeter with a central rectangular recess. That is, the adhesion element (806) may define an opening such that, for example, tissue indented against the adhesion element (806) forms a rectangular indent around the perimeter formed by the raised portion of the adhesion element (806). Energy may be supplied to activate the adhesion element (806) to adhere two vessels together. In some variations, an opposing adhesion element on a second catheter may be configured to fit within the central rectangular recess, which may allow for increased pressure application to tissue located between the adhesion element (806) and the opposing adhesion element.


In some variations, the catheters described herein may be configured to have adjustable stiffness, for example in the event that an increase in pushability, flexibility, or torquability may be desired. For example, FIGS. 9A-9E show side and perspective views of variations of a catheter (900) similar to catheter (700) comprising a proximal portion (904) and a distal portion (906) comprising an adhesion element (908) having a flat contact surface. The distal portion (906) may be fixedly connected to an inner proximal portion (904) and may have a larger cross-sectional dimension than the inner proximal portion (904). The inner proximal portion (904) may be slidable within an outer proximal portion (902), where the outer proximal portion comprises a tubular shape. As such, the distal portion (906) and part of the inner proximal portion (904) may be configured to extend distally from the outer proximal portion (902) between a retracted position (FIGS. 9A-9C) and an extended configuration (FIGS. 9D-9E). In the extended configuration shown in FIGS. 9D-9E, the distal portion (906) of the catheter (900) may have increased ability to deform and/or press into tissue when the adhesion element (908) is attracted to a corresponding adhesion element of another catheter, since deformation of the inner proximal portion (904) is not limited by the outer proximal portion (902). In the retracted configuration shown in FIGS. 9A-9C, the distal portion (906) of the catheter (900) may have increased pushability, since deformation of the inner proximal portion (904) is limited by the outer proximal portion (902). In this way, either of the extended or retracted configurations (or an intermediate configuration between the extended or retracted configurations) may be selected based on one more requirements related to pushability, flexibility, and/or torquability.


In FIGS. 2A-4 and 7-9E, the adhesion elements are shown at or near a distal end of the catheters. However, it should be appreciated that adhesion elements may be located along any suitable portion of the catheters described herein (e.g., a distal end, an intermediate portion, or combinations thereof). It should also be appreciated that a catheter may have any suitable number (e.g., zero, one, two, three, or four or more) and combination of adhesion elements. In variations in which a catheter comprises two or more adhesion elements, multiple adhesion elements may be used to create multiple adhesion regions, either simultaneously or sequentially. In other variations, multiple adhesion elements may interact to form a single adhesion region.


Furthermore, in other variations, an adhesion element need not comprise a magnet. While magnetic adhesion elements may help to compress tissue between two catheters, in some variations the adhesion elements may comprise any material suitable for heating tissue to cause adhesion. For example, the adhesion elements may comprise any suitable conductive material. In some of these variations, the catheters described herein may comprise one or more adhesion elements and one or more separate alignment features to assist in coaption and rotational and/or axial alignment of the catheters relative to each other. In some of these variations, alignment features may assist a user in manual positioning of the catheters. Generally, in these variations, the catheters may comprise at least one of a flat coaption surface, a magnet, and a rotational indicator. Combinations of one or more of these elements may improve the ability of a user to orient and align catheters rotationally. For instance, the catheters described herein may comprise one or more adhesion elements and a separate coaption region comprising one or more magnets to promote coaption and alignment. For example, a catheter may comprise a magnet and a separate adhesion element comprising an electrode. FIG. 10 is a perspective view of such a variation of a catheter (1000) comprising a magnet (1002) and a separate electrode (1006). The magnet (1002) may be separated from the electrode (1006) by an electrical and/or thermal insulator (1004). The thermal insulator may comprise, for example, polyimide, PEEK, PTFE, and/or ceramic. In this configuration, the magnet (1002) may act to promote tissue compression between the flat contact surface of the adhesion element (electrode (1006)) and an adhesion element in an adjacent vessel and may promote proper alignment between the adhesion elements, while the electrode (1006) may act as the adhesion element. In other variations, the electrode (1006) may be disposed directly on the magnet (1002).



FIGS. 11A-11B illustrate another variation of a system in vasculature comprising a first catheter (1100) in a first blood vessel (1106) and a second catheter (1108) in a second blood vessel (1114). The first catheter (1100) may comprise a first adhesion element (1102) that may be a non-magnetic adhesion element, such as a non-magnetic electrode, and the second catheter (1108) may comprise a second adhesion element (1110) that may be non-magnetic adhesion element, such as a non-magnetic electrode. It should be appreciated that in other variations, the first and second adhesion elements (1102, 1110) may comprise magnetic electrodes. The adhesion elements (1102, 1110) may be connected via electrical leads (1116, 1118) to a power source (not shown), as described in more detail herein. The first catheter (1100) may further comprise a first coaption region (1104) comprising one or more magnets that may be distal and proximal to the first adhesion element (1102). The second catheter (1108) may further comprise a second coaption region (1112) comprising one or more magnets that may be distal and proximal to the second adhesion element (1110). Generally, the magnets may be configured to be attracted to one or more magnetic fields (e.g., produced by one or more magnets of the other catheter). The magnets may help to align or otherwise reposition the catheters (1000, 1108) when placed in the vasculature. Once the first and second catheters (1000, 1108) have been positioned, the attractive magnetic forces may also act to maintain the relative positions of the catheters (1000, 1108). When the first and second catheters (1000, 1108) are placed in respective blood vessels (1106, 1114), tissue positioned between the blood vessels and/or limited compliance of the blood vessels may limit the extent to which the magnets of the first and second catheters bring the first and second catheters toward each other. The magnets may additionally or alternatively help to ensure that the catheters (1000, 1108) are in proper axial and/or rotational alignment relative to each other. Such axial and/or rotational alignment of the catheters (1000, 1108) may also facilitate alignment of the adhesion elements (1102, 1110) relative to a target location for vessel adhesion.


It should be appreciated that the catheters of the systems described here may comprise one or more magnets, and each catheter may comprise any number of individual magnets (e.g., one, two, three, four, five, six, seven, or eight or more, etc.). In some variations in which a catheter comprises multiple magnets, one or more magnets may act as adhesion elements and be configured to heat tissue (e.g., through delivery of electrical current), while one or more other magnets may not be configured to heat tissue. In variations in which a catheter comprises a plurality of magnets, these magnets may be grouped into one or more magnet arrays. The magnets may be located inside and/or outside of a catheter body. The magnets may be positioned at any suitable location along the length of the catheter. Generally, the dimensions of the magnets described herein may be selected based on the size of the catheters carrying the magnets, which in turn may be selected based on the anatomical dimensions of the blood vessels through which the catheters may be advanced. For example, if the catheter is to be advanced through a blood vessel having an internal diameter of about 3 mm, it may be desirable to configure any magnet to be less than about 3 mm at the widest part of its cross-section, to reduce the risk of injury to vessel walls during advancement and manipulation of the catheter. Each magnet may have any suitable length (e.g., about 5 mm, about 10 mm, about 15 mm, about 20 mm, or the like), although it should be appreciated that in some instances longer magnets may limit the flexibility of the catheter to maneuver through tissue.


The magnets described here throughout may be permanent magnets comprising one or more hard magnetic materials, such as but not limited to alloys of rare earth elements (e.g., samarium-cobalt magnets or neodymium magnets, such as N52 magnets) or alnico. In some variations, the magnets may comprise anisotropic magnets; in other variations, the magnets may comprise isotropic magnetics. In some variations, the magnets may be formed from compressed powder. In some variations, a portion of the magnets (e.g., a permeable backing) may comprise one or more soft magnetic materials, such as but not limited to iron, cobalt, nickel, or ferrite. When the magnets are configured to deliver electrical current to tissue, the magnets may comprise conductive material and/or comprise a conductive coating. When the magnets are located within the catheter, as in FIGS. 11A-11B for example, given the limitations on magnet size, it may be desirable in some instances to use magnets configured to produce magnetic fields that increase the magnetic force that can be generated with a magnet of a given size. For example, in some variations the system may comprise one or more of the magnets described in U.S. patent application Ser. No. 14/214,503, filed on Mar. 14, 2014, and titled “FISTULA FORMULATION DEVICES AND METHODS THEREFOR,” and/or U.S. patent application Ser. No. 14/657,997, filed on Mar. 13, 2015, and titled “FISTULA FORMATION DEVICES AND METHODS THEREFOR,” each of which is hereby incorporated by reference in its entirety.


It should be appreciated that while some of the systems described here comprise a first catheter and a second catheter each comprising one or more permanent magnets (which may or may not be configured to heat tissue), in other variations either the first or second catheter may comprise ferromagnetic elements (i.e., elements attracted to but not generating a permanent magnetic field). For example, in some variations, the first catheter may include only one or more ferromagnetic elements while the second catheter comprises one or more permanent magnets. In other variations, the second catheter may include only one or more ferromagnetic elements while the first catheter comprises one or more permanent magnets. However, in other variations, one or both of the first and second catheters may include any suitable combination of ferromagnetic, permanent, and/or other suitable kinds of magnets.


Returning to FIG. 11A-11B, these figures illustrate the catheters (1100, 1108) advanced through respective vessels (1106, 1114). When the catheters (1100, 1108) are brought together, the attractive magnetic forces of the magnets within the coaption regions (1104, 1112) may bring the catheters (1100, 1108) and blood vessels (1106, 1114) in closer approximation, as shown in FIG. 11B. In variations where the adhesion elements are magnetic, the adhesion elements may also bring the catheters together. One or more of the adhesion elements (1102, 1108) may then be energized so as to apply heat to the vessels, as described in more detail herein.


The systems described herein may further comprise one or more additional alignment features to help ensure that the catheters are axially and/or rotationally aligned prior to heating the tissue to achieve adhesion. For example, one or both of the first and second catheters may comprise a visual alignment aid for indirectly visualizing the alignment of a catheter within a tubular structure or relative to another catheter, such as via fluoroscopy, during positioning and/or alignment thereof.


In some variations, the visual alignment aid may comprise a rotational indicator. A rotational indicator may serve as a visual marker for guiding rotational alignment of two catheters as viewed under fluoroscopy. The rotational indicators of each catheter may be used to rotationally and/or axially position the catheters such that that one or more adhesion elements are properly positioned to adhere tissue. Generally, a rotational indicator may be configured such that its rotational orientation is discernable in a two-dimensional fluoroscopic image. A rotational indicator may comprise a radiopaque portion. The first catheter may include a first radiopaque portion and the second catheter may include a corresponding second radiopaque portion. An X-ray beam may fluoroscopically image an orientation of the first radiopaque portion and the second radiopaque portion, and the image may be shown on a display for a user. The user may then manipulate one or both of the catheters to align the catheters. A rotational indicator may be provided along any suitable portion of the catheter. In some variations, the rotational indicator may comprise any radiopaque metal, such as tungsten, platinum iridium, stainless steel, titanium, as well as a tungsten filled polymer, zirconia ceramic, or any suitable radiopaque material. In some variations, the rotational indicator may comprise a radiopaque film Rotational indicators suitable for use in the catheters described herein are discussed in more detail in U.S. patent application Ser. No. 15/406,755, filed Jan. 15, 2017, titled “DEVICES AND METHODS FOR FORMING A FISTULA” and claiming the benefit of U.S. Provisional Application No. 62/399,471, filed Sep. 25, 2016, and U.S. Provisional Application No. 62/279,603, filed Jan. 15, 2016, which is hereby incorporated by reference in its entirety.


II. Methods


Also described here are methods for adhering tissue of two tubular structures, such as two blood vessels. When the tubular structures comprise blood vessels, the two blood vessels may be two closely-associated blood vessels, such as a vein and an artery, two veins, two arteries, or the like. Generally, when the tubular structures are blood vessels, the methods described here comprise accessing a first blood vessel with a first catheter having features as described herein, and advancing the first catheter to a target location within the first blood vessel. A second blood vessel may be accessed with a second catheter having features as described herein, and the second catheter may be advanced to a target location within the second vessel. After the vessels are brought toward each other and aligned, one or more adhesion elements may be activated to heat and denature tissue to fuse tissue together and form an adhesion between the two vessels. The catheters may then be removed. In some variations, a fistula may be formed through a portion of the welded tissue. In some instances, a fistula may be formed using the devices, systems, and methods in U.S. patent application Ser. No. 13/298,169, filed on Nov. 16, 2011, and titled “DEVICES AND METHODS FOR FORMING A FISTULA,” which is hereby incorporated by reference in its entirety, and in U.S. patent application Ser. No. 15/406,755, filed Jan. 15, 2017, titled “DEVICES AND METHODS FOR FORMING A FISTULA” and claiming the benefit of U.S. Provisional Application No. 62/399,471, filed Sep. 25, 2016, and U.S. Provisional Application No. 62/279,603, filed Jan. 15, 2016, which was previously incorporated by reference in its entirety, while in other variations, the devices and systems described herein may be used to form a fistula.


When the tubular structures are blood vessels, advancement of one or more catheters through a vessel to a target site is not particularly limited. In some variations, a first catheter is advanced into an artery, and a second catheter is advanced into a vein. In other variations, a first catheter is advanced into a first vein, and a second catheter is advanced into a second vein. In still other variations, a first catheter is advanced into a first artery and a second catheter is advanced into a second artery. In some variations, a first catheter is advanced into a vein, and the second catheter is advanced into an artery. The first and/or second catheters may be advanced over a guidewire or in any suitable manner and may or may not occur under indirect visualization (e.g., via fluoroscopy, X-ray, or ultrasound).


In some variations, each of the first or second catheters may comprise one or more adhesion elements as described herein. The adhesion elements may or may not be magnetic. In some variations, aligning the first and second catheters may comprise axial and/or rotational alignment of the adhesion elements. In variations where both the first and second catheters comprise adhesion elements, the catheters may be oriented to align these adhesion elements. The catheters may be aligned in any suitable manner. In some variations, magnetic adhesion elements may generate an attractive force between the first and second catheters, which may pull the catheters toward each other. In these or other variations, separate coaption regions may comprise one or more magnets configured to generate an attracted force between the first and second catheters.


Additionally or alternatively, the catheter systems described herein may comprise one or more rotational indicators allowing for indirect visualization of catheter alignment such as through fluoroscopy. In variations where the first and/or second catheters comprise one or more rotational indicators, such as those described herein, the markers may be viewed (e.g., via fluoroscopy, X-ray, or the like) to ensure that the catheters have the proper axial and/or radial orientation relative to each other. For example, the catheter and rotational indicators may be visualized fluoroscopically during alignment of the catheters, and in some cases from at least advancement steps through alignment of the catheters. The user may view the rotational indicators in a fluoroscopic image to determine a rotational alignment of the catheters and may rotate the catheters until alignment is achieved. When the catheters are viewed as axially aligned based on the position of the rotational indicators or another portion of the catheters, the user may bring the catheters into close approximation.


Once the catheters are aligned, one or more adhesion elements may be activated to adhere tissue in vessels. As shown in FIG. 12A, one or more adhesion elements may form a thermal weld (1206) between a first vessel (1202) and a second vessel (1204). FIG. 12B is a plan view of the vessel (1202) having a formed weld (1206) in the shape of the adhesion element in contact with the vessel (1202). In some instances, tissue may be heated to form a thermal weld between the intimal, medial, and/or adventitia of the vessels (1202, 1204). The weld (1206) may form a hermetic seal between the vessels, thereby preventing pressurized fluid from ingress or egress through the weld plane. The weld may also be strong enough to prevent the vessels from being pulled apart under forces that may be applied due to bodily function or motion. In other instances, the weld (1206) may be able to withstand internal hydraulic pressure from dissecting the vessels apart, as discussed in further detail herein. In some variations, the weld may have a width of about 0.1 mm to about 15 mm and a length ranging from about 0.1 mm to about 10 cm, although the weld length may vary from this range. In some variations, a plurality of discrete welds may be produced by a single catheter system using a plurality of adhesion elements.


The adhesion elements may adhere tissue by heating the tissue. In some variations, the adhesion elements may heat tissue by delivering radiofrequency energy. In other variations, the adhesion elements may be heated through ohmic heating, which may in turn heat tissue. In yet other variations, the adhesion elements may deliver laser energy to heat tissue, or may deliver ultrasonic energy to heat tissue.


In some variations, the systems discussed herein may comprise an electrosurgical controller coupled to one or more adhesion elements for controlling tissue adhesion. A controller may control the energy delivery to one more adhesion elements to heat tissue based on the selected adhesion parameters. Adhesion parameters may include an energy waveform shape, frequency, amplitude, duration, and so forth. For example, in one non-limiting variation, a controller may be configured to deliver a waveform having a frequency between about 300 kHz and about 500 kHz, with a peak voltage of between about 120 V and about 140 V. In some variations, a controller may be configured to deliver a waveform having a frequency of about 400 kHz, with a peak voltage of about 130 V. The waveform may have any suitable shape, such as a sinusoidal or square shape. The controller may modulate one or more parameters to achieve a desired heating profile. For example, the controller may modulate one or more of the peak voltage or duty cycle of the waveform. In some variations, the electrosurgical controller may deliver energy for a predetermined duration to achieve the intended adhesion. In other variations, the strength of an adhesion cycle may be limited in power and/or duration so as to perform a plurality of adhesion cycles. In this manner, the thermal effects of heating may be dispersed over a longer period of time so as to limit collateral thermal injury to the vessel.


In some variations, tissue parameters may be measured and analyzed in order to determine one or more adhesion parameters. The electrosurgical controller may in some instances monitor the impedance during energy delivery to determine a rate of tissue heating. In other instances, termination of adhesion may occur after measuring a predetermined impedance or a predetermined rate of change of impedance. In order to measure impedance, the system may comprise an impedance metering circuit such as a bipolar sensing circuit with each adhesion element serving as an element. To measure impedance, low power DC or alternating voltage may be applied to the adhesion elements. The resulting current and/or phase may then be measured to determine impedance. Additionally or alternatively, impedance may also be measured during a thermal adhesion period by measuring the impedance in a bipolar or monopolar circuit. In this manner, a single heating cycle may be performed without interrupting the energy delivery cycle to measure impedance. Impedances measured before, after, and/or during an adhesion sequence may determine the level of vessel modification provided. Additionally or alternatively, a catheter may further comprise a thermocouple or thermistor to monitor tissue temperature as an additional input signal for controlling adhesion by the electrosurgical controller. In some variations, one or more impedance measurements or tissue temperature measurements may be outputted to a user as one or more of visual and audio feedback. For example, the system may output an impedance value on a display meter coupled to the catheters. Impedance values may be output as audio tones. In other variations, impedance measurements or tissue temperature information may be provided to the electrosurgical controller to automatically adjust or stop current delivery. For example, tissue measurements indicating that the temperature has reached 70° C. may indicate that protein denaturation has been achieved.


After tissue adhesion is performed using one or more adhesion elements, in some variations a fenestration between the two tubular structures may optionally be formed. In some variations, a fenestration may be formed using different devices, such as a different catheter system For example, a fistula between the two vessels may be formed using a system and method as described in U.S. patent application Ser. No. 13/298,169, filed on Nov. 16, 2011, and titled “DEVICES AND METHODS FOR FORMING A FISTULA,” and in U.S. patent application Ser. No. 15/406,755, filed Jan. 15, 2017, titled “DEVICES AND METHODS FOR FORMING A FISTULA” and claiming the benefit of U.S. Provisional Application No. 62/399,471, filed Sep. 25, 2016, and U.S. Provisional Application No. 62/279,603, filed Jan. 15, 2016, each of which was previously incorporated by reference in its entirety. For example, a fistula may be formed using a system comprising a first catheter and a second catheter. The first catheter may comprise a catheter body, one or more magnetic elements, and a fistula-forming element. The second catheter may comprise a catheter body, one or more magnetic elements, and may optionally comprise a fistula-forming element. In some variations, the fistula-forming element may comprise an electrode configured to move between a low-profile configuration and an extended configuration in which it extends radially away from the catheter body. In some variations the fistula-forming element may be spring-biased toward the extended configuration, i.e., may be configured to self-expand from the low-profile to the extended configuration, and may be held in the low-profile configuration during placement, for example by an external radially inward force on the electrode from a the catheter body or a vessel wall during delivery.


In other variations, a fenestration may be formed using the same catheters but using a separate fistula-forming element. For example, the separate fistula-forming element may be axially displaced along the catheter from the adhesion element, or as another example, a separate fistula-forming element may be located within an adhesion element. In the case of a fistula formed between blood vessels, hemostasis may be created without the need for a separate device or structure (e.g., a suture, stent, shunt, or the like) connecting or joining the blood vessels. In yet other variations, a fenestration may be formed by further activating the adhesion elements to bore through, perforate, or otherwise create a passageway between the two structures (e.g., blood vessels such that blood may flow directly between the two adjoining blood vessels). In some variations in which a fenestration is formed, a first current may be applied to the adhesion element to adhere tissue together while a second current may be applied to form an opening through the tissue in the shape of the adhesion element. For example, the waveform may be modified to have an increased peak voltage. For example, the peak voltage may be increased to reach an ionization threshold. In one non-limiting example, the peak voltage may be increased to about 180 V. In other variations, energy supplied to an adhesion element for a first time period may adhere the two vessels together while continued heating for a second time period beyond the first time period may form a fistula. In one non-limiting example, the first time period may be up to about 10 seconds, while the second time period may be up to an additional about 5 seconds.


In variations in which a fistula is formed between the two vessels after adhesion, the weld may maintain adhesion of the two attached vessels when the fistula is subsequently formed in the weld. In other words, a weld may prevent pressurized fluids traveling through the fistula from breaching the hermetic seal. In this way, the weld may prevent extravasation or leaking of fluids and thus may provide an enhanced fistula. FIG. 13A shows a cross-sectional view of a thermal weld (1306) surrounding a fistula (1308) between a first vessel (1302) and a second vessel (1304). FIG. 13B shows a plan view of the vessel (1302) and weld (1306) and a fistula (1308) formed therethrough to provide fluid communication through the fistula (1308) while maintaining a perimeter of welded tissue (1306) to prevent fluid leakage.


Although the foregoing variations have, for the purposes of clarity and understanding, been described in some detail by of illustration and example, it will be apparent that certain changes and modifications may be practiced, and are intended to fall within the scope of the appended claims. Additionally, it should be understood that the components and characteristics of the devices and methods described herein may be used in any appropriate combination. The description of certain elements or characteristics with respect to a specific figure are not intended to be limiting or nor should they be interpreted to suggest that the element cannot be used in combination with any of the other described elements.

Claims
  • 1. A system for adhering two tubular structures together, comprising: a first catheter comprising a first adhesion element embedded within a portion of the first catheter, wherein the first adhesion element is magnetic and comprises a flat, magnetic contact surface;a second catheter comprising a second adhesion element embedded within a portion of the second catheter, wherein the second adhesion element is magnetic and comprises a flat, magnetic contact surface, wherein each of the first and second adhesion elements comprises a resistor for ohmic heating; anda power source connected to the resistor of the first and second adhesion elements, wherein the flat, magnetic contact surfaces are heated in response to heating the resistor to a temperature sufficient to form a thermal weld between the two tubular structures via the flat, magnetic contact surfaces of the first adhesion element and the second adhesion element, the thermal weld providing a hermetic seal preventing egress of a fluid through a thermal weld plane;wherein the first catheter comprises a proximal portion and a distal portion, wherein the largest cross-sectional dimension of the distal portion is larger than the largest cross-sectional dimension of the proximal portion, and wherein the first adhesion element is located on the distal portion; wherein the second catheter comprises a second proximal portion and a second distal portion, wherein the largest cross-sectional dimension of the second distal portion is larger than the largest cross-sectional dimension of the second proximal portion, and wherein the second adhesion element is located on the second distal portion.
  • 2. The system of claim 1, wherein the first adhesion element is located at a distal end of the first catheter, and the second adhesion element is located at a distal end of the second catheter.
  • 3. The system of claim 1, wherein the first adhesion element is coated with one or more layers of a fluoropolymer.
  • 4. The system of claim 1, wherein at least one of the pushability, flexibility, or torquability of the first catheter is adjustable.
  • 5. The system of claim 1, wherein the first catheter comprises a distal portion, an inner proximal portion, and an outer proximal portion.
  • 6. The system of claim 5, wherein the outer proximal portion is slidable relative to the distal portion.
  • 7. The system of claim 6, wherein the distal portion is configured to extend away from the outer proximal portion when moved from a retracted configuration to an extended configuration.
  • 8. The system of claim 1, further comprising a rotational indicator.
  • 9. The system of claim 1, wherein the first adhesion element defines a recess.
  • 10. The system of claim 1, wherein the power source comprises a controller configured to control energy delivery to the catheters.
  • 11. The system of claim 10, wherein the controller is configured to: supply a first current to the resistor for forming the thermal weld; andsupply a second current to the resistor for forming a fenestration within the thermal weld.
  • 12. The system of claim 1, wherein the first adhesion element has a square cross section.
  • 13. The system of claim 1, wherein the first adhesion element has a triangular cross section.
  • 14. The system of claim 1, wherein the first adhesion element has a hexagonal cross section.
  • 15. The system of claim 1, wherein the first adhesion element has a rectangular cross section.
  • 16. The system of claim 1, wherein the first adhesion element has a semi-circular cross section.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of International Application No. PCT/US2017/013611, filed Jan. 15, 2017, which claims the benefit of U.S. Provisional Application No. 62/279,642, filed Jan. 15, 2016, and titled “SYSTEMS AND METHODS FOR ADHERING VESSELS,” each of which is hereby incorporated by reference in its entirety.

US Referenced Citations (356)
Number Name Date Kind
3649850 Davis Mar 1972 A
3827436 Stumpf et al. Aug 1974 A
4416664 Womack Nov 1983 A
4802475 Weshahy Feb 1989 A
5313943 Houser et al. May 1994 A
5383460 Jang et al. Jan 1995 A
5429131 Scheinman Jul 1995 A
5697909 Eggers et al. Dec 1997 A
5782239 Webster, Jr. Jul 1998 A
5800487 Mikus et al. Sep 1998 A
5830222 Makower Nov 1998 A
5830224 Cohn et al. Nov 1998 A
5836947 Fleischman et al. Nov 1998 A
5895404 Ruiz Apr 1999 A
5971979 Joye et al. Oct 1999 A
6004330 Middleman et al. Dec 1999 A
6032677 Blechman et al. Mar 2000 A
6039730 Rabin et al. Mar 2000 A
6068638 Makower May 2000 A
6071274 Thompson et al. Jun 2000 A
6099542 Cohn et al. Aug 2000 A
6159225 Makower Dec 2000 A
6190353 Makower et al. Feb 2001 B1
6197025 Grossi et al. Mar 2001 B1
6217575 DeVore et al. Apr 2001 B1
6231587 Makower May 2001 B1
6256525 Yang et al. Jul 2001 B1
6280440 Gocho Aug 2001 B1
6283988 Laufer et al. Sep 2001 B1
6287306 Kroll et al. Sep 2001 B1
6302875 Makower et al. Oct 2001 B1
6327505 Medhkour et al. Dec 2001 B1
6347247 Dev et al. Feb 2002 B1
6355029 Joye et al. Mar 2002 B1
6357447 Swanson et al. Mar 2002 B1
6379353 Nichols Apr 2002 B1
6383180 Lalonde et al. May 2002 B1
6394956 Chandrasekaran et al. May 2002 B1
6400976 Champeau Jun 2002 B1
6428534 Joye et al. Aug 2002 B1
6461356 Patterson Oct 2002 B1
6464665 Heuser Oct 2002 B1
6464723 Callol Oct 2002 B1
6468268 Abboud et al. Oct 2002 B1
6475214 Moaddeb Nov 2002 B1
6475226 Belef et al. Nov 2002 B1
6527724 Fenici Mar 2003 B1
6527769 Langberg et al. Mar 2003 B2
6542766 Hall et al. Apr 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6569158 Abboud et al. May 2003 B1
6569162 He May 2003 B2
6579311 Makower Jun 2003 B1
6585650 Solem Jul 2003 B1
6592577 Abboud et al. Jul 2003 B2
6629987 Gambale et al. Oct 2003 B1
6635053 Lalonde et al. Oct 2003 B1
6655386 Makower et al. Dec 2003 B1
6656173 Palermo Dec 2003 B1
6663625 Ormsby et al. Dec 2003 B1
6669709 Cohn et al. Dec 2003 B1
6673085 Berg Jan 2004 B1
6676657 Wood Jan 2004 B2
6682525 Lalonde et al. Jan 2004 B2
6695878 McGuckin et al. Feb 2004 B2
6709444 Makower Mar 2004 B1
6719756 Muntermann Apr 2004 B1
6726697 Nicholas et al. Apr 2004 B2
6733494 Abboud et al. May 2004 B2
6736808 Motamedi et al. May 2004 B1
6761708 Chiu et al. Jul 2004 B1
6761714 Abboud et al. Jul 2004 B2
6780181 Kroll et al. Aug 2004 B2
6849073 Hoey et al. Feb 2005 B2
6855143 Davison et al. Feb 2005 B2
6887234 Abboud et al. May 2005 B2
6911026 Hall et al. Jun 2005 B1
6932814 Wood Aug 2005 B2
6936024 Houser Aug 2005 B1
6960209 Clague et al. Nov 2005 B2
6971983 Cancio Dec 2005 B1
6981972 Farley et al. Jan 2006 B1
7059330 Makower et al. Jun 2006 B1
7060063 Marion et al. Jun 2006 B2
7094235 Francischelli Aug 2006 B2
7155293 Westlund et al. Dec 2006 B2
7179270 Makower Feb 2007 B2
7189231 Clague et al. Mar 2007 B2
7214234 Rapacki et al. May 2007 B2
7231260 Wallace et al. Jun 2007 B2
7250051 Francischelli Jul 2007 B2
7288075 Parihar et al. Oct 2007 B2
7303554 Lalonde et al. Dec 2007 B2
7306598 Truckai et al. Dec 2007 B2
7335198 Eggers et al. Feb 2008 B2
7341063 Garbibaldi et al. Mar 2008 B2
7367341 Anderson et al. May 2008 B2
7374567 Heuser May 2008 B2
7387636 Cohn et al. Jun 2008 B2
7407506 Makower Aug 2008 B2
7522950 Fuimaono et al. Apr 2009 B2
7628768 Faul et al. Dec 2009 B2
7702387 Stevenson et al. Apr 2010 B2
7727268 Cunniffe et al. Jun 2010 B2
7744596 Young et al. Jun 2010 B2
7811281 Rentrop Oct 2010 B1
7828814 Brenneman et al. Nov 2010 B2
7846172 Makower Dec 2010 B2
7849860 Makower et al. Dec 2010 B2
7857809 Drysen Dec 2010 B2
7881797 Griffin et al. Feb 2011 B2
7955326 Paul et al. Jun 2011 B2
7967769 Faul et al. Jun 2011 B2
7967770 Li et al. Jun 2011 B2
8010208 Nimer et al. Aug 2011 B2
8048016 Faul et al. Nov 2011 B2
8052680 Hassett et al. Nov 2011 B2
8062321 Heuser et al. Nov 2011 B2
RE43007 Lalonde et al. Dec 2011 E
8075555 Truckai et al. Dec 2011 B2
8088171 Brenneman Jan 2012 B2
8100899 Doty et al. Jan 2012 B2
8118809 Paul et al. Feb 2012 B2
8135467 Markowitz et al. Mar 2012 B2
8142454 Harrison et al. Mar 2012 B2
8192425 Mirza et al. Jun 2012 B2
8200466 Spilker et al. Jun 2012 B2
8226592 Brenneman et al. Jul 2012 B2
8231618 Viswanathan et al. Jul 2012 B2
8236014 Brenneman et al. Aug 2012 B2
8262649 Francischelli Sep 2012 B2
8273095 Brenneman et al. Sep 2012 B2
8328797 Wilson et al. Dec 2012 B2
8333758 Joye et al. Dec 2012 B2
8361061 Esch et al. Jan 2013 B2
8366707 Kassab et al. Feb 2013 B2
8382697 Brenneman et al. Feb 2013 B2
8409196 Durgin et al. Apr 2013 B2
8413664 Appling Apr 2013 B2
8414572 Davison et al. Apr 2013 B2
8419681 Sell Apr 2013 B2
8439909 Wang et al. May 2013 B2
8454587 Lalonde et al. Jun 2013 B2
8475441 Babkin et al. Jul 2013 B2
8486062 Belhe et al. Jul 2013 B2
8486064 Van Wyk et al. Jul 2013 B2
8551032 Faul et al. Oct 2013 B2
8574185 Faul et al. Nov 2013 B2
8585700 Katou Nov 2013 B2
8608754 Wensel et al. Dec 2013 B2
8641724 Brenneman et al. Feb 2014 B2
8649879 DiGiore et al. Feb 2014 B2
8676309 Deem et al. Mar 2014 B2
8685014 Babkin et al. Apr 2014 B2
8700179 Pianca et al. Apr 2014 B2
8715281 Barlow et al. May 2014 B2
8758334 Coe et al. Jun 2014 B2
8771267 Kunis et al. Jul 2014 B2
8784409 Robilotto et al. Jul 2014 B2
8790341 Pappone et al. Jul 2014 B2
8876699 Sato et al. Nov 2014 B2
8876815 Coe et al. Nov 2014 B2
8882765 Kassab et al. Nov 2014 B2
8911435 Katoh et al. Dec 2014 B2
8951251 Willard Feb 2015 B2
9017323 Miller et al. Apr 2015 B2
9039702 Miller et al. May 2015 B2
9072880 Phillips et al. Jul 2015 B2
9089316 Baust et al. Jul 2015 B2
9108018 Dickinson et al. Aug 2015 B2
9155827 Franano Oct 2015 B2
9204916 Lalonde Dec 2015 B2
9259340 Heuser et al. Feb 2016 B2
9283034 Katoh et al. Mar 2016 B2
9307992 Wilson et al. Apr 2016 B2
9314329 Dickinson et al. Apr 2016 B2
9326792 Dickinson et al. May 2016 B2
9364280 Zarins et al. Jun 2016 B2
9402560 Organ et al. Aug 2016 B2
9414885 Willard Aug 2016 B2
9439728 Hull et al. Sep 2016 B2
9445868 Hull et al. Sep 2016 B2
9452015 Kellerman et al. Sep 2016 B2
9486276 Rios et al. Nov 2016 B2
9510901 Steinke et al. Dec 2016 B2
9623217 Pillai Apr 2017 B2
9706998 Dickinson et al. Jul 2017 B2
9782201 Dickinson et al. Oct 2017 B2
9782533 Brenneman et al. Oct 2017 B2
10045817 Miller et al. Aug 2018 B2
10265206 Heuser et al. Apr 2019 B2
10517637 Dickinson et al. Dec 2019 B2
10543308 Lenihan et al. Jan 2020 B2
10575974 De Pablo Peña et al. Mar 2020 B2
10596356 Lenihan et al. Mar 2020 B2
20010029384 Nicholas et al. Oct 2001 A1
20020072739 Lee et al. Jun 2002 A1
20020113678 Creighton Aug 2002 A1
20020151945 Gobin et al. Oct 2002 A1
20030009163 Messing et al. Jan 2003 A1
20030220674 Anderson et al. Nov 2003 A1
20040059211 Patel et al. Mar 2004 A1
20040059280 Makower et al. Mar 2004 A1
20040098095 Burnside et al. May 2004 A1
20040167506 Chen Aug 2004 A1
20040215220 Dolan et al. Oct 2004 A1
20040236360 Cohn et al. Nov 2004 A1
20050033401 Cunniffe et al. Feb 2005 A1
20050065509 Coldwell et al. Mar 2005 A1
20050245925 Iki et al. Nov 2005 A1
20050251120 Anderson et al. Nov 2005 A1
20060079897 Harrison et al. Apr 2006 A1
20060111704 Brenneman et al. May 2006 A1
20070173878 Heuser Jul 2007 A1
20070185567 Heuser et al. Aug 2007 A1
20070203515 Heuser et al. Aug 2007 A1
20070203572 Heuser et al. Aug 2007 A1
20070293856 Paul et al. Dec 2007 A1
20080021532 Kveen et al. Jan 2008 A1
20080039830 Munger Feb 2008 A1
20080051626 Sato et al. Feb 2008 A1
20080065019 Heuser et al. Mar 2008 A1
20080091192 Paul et al. Apr 2008 A1
20080119879 Brenneman May 2008 A1
20080140061 Toubia et al. Jun 2008 A1
20080161901 Heuser et al. Jul 2008 A1
20080171944 Brenneman et al. Jul 2008 A1
20080183164 Elkins et al. Jul 2008 A1
20080188848 Deutmeyer et al. Aug 2008 A1
20080221519 Schwach et al. Sep 2008 A1
20080275442 Paul et al. Nov 2008 A1
20080312577 Drasler et al. Dec 2008 A1
20090036872 Fitzgerald et al. Feb 2009 A1
20090076324 Takayama et al. Mar 2009 A1
20090093791 Heuser Apr 2009 A1
20090112119 Kim Apr 2009 A1
20090118722 Ebbers et al. May 2009 A1
20090124847 Doty May 2009 A1
20090157014 Osborne et al. Jun 2009 A1
20090187098 Makower et al. Jul 2009 A1
20090198232 Young et al. Aug 2009 A1
20090248148 Shaolian et al. Oct 2009 A1
20090275876 Brenneman et al. Nov 2009 A1
20090281379 Binmoeller et al. Nov 2009 A1
20090318849 Hobbs et al. Dec 2009 A1
20100004623 Hamilton, Jr. et al. Jan 2010 A1
20100010488 Kassab et al. Jan 2010 A1
20100082058 Kassab Apr 2010 A1
20100130835 Brenneman et al. May 2010 A1
20100198206 Levin Aug 2010 A1
20100204691 Bencini Aug 2010 A1
20100222664 Lemon et al. Sep 2010 A1
20100256616 Katoh et al. Oct 2010 A1
20100280316 Dietz et al. Nov 2010 A1
20100280514 Zerfas et al. Nov 2010 A1
20100286705 Vassiliades, Jr. Nov 2010 A1
20100292685 Katoh et al. Nov 2010 A1
20100298645 Deutch Nov 2010 A1
20100318180 Porter Dec 2010 A1
20110015657 Brenneman et al. Jan 2011 A1
20110112427 Phillips et al. May 2011 A1
20110118735 Abou-Marie et al. May 2011 A1
20110201990 Franano Aug 2011 A1
20110213309 Young et al. Sep 2011 A1
20110218476 Kraemer et al. Sep 2011 A1
20110270149 Faul et al. Nov 2011 A1
20110288392 de la Rama et al. Nov 2011 A1
20110288544 Verin et al. Nov 2011 A1
20110306959 Kellerman Dec 2011 A1
20110306993 Hull Dec 2011 A1
20110319976 Iyer et al. Dec 2011 A1
20120010556 Faul et al. Jan 2012 A1
20120022518 Levinson Jan 2012 A1
20120035539 Tegg Feb 2012 A1
20120046678 LeMaitre et al. Feb 2012 A1
20120059398 Pate et al. Mar 2012 A1
20120065652 Cully et al. Mar 2012 A1
20120078342 Vollkron et al. Mar 2012 A1
20120089123 Organ et al. Apr 2012 A1
20120101423 Brenneman Apr 2012 A1
20120116354 Heuser May 2012 A1
20120157992 Smith et al. Jun 2012 A1
20120209377 MacHold et al. Aug 2012 A1
20120215088 Wang et al. Aug 2012 A1
20120239021 Doty et al. Sep 2012 A1
20120277736 Francischelli Nov 2012 A1
20120281330 Abbott et al. Nov 2012 A1
20120289953 Berzak et al. Nov 2012 A1
20120296262 Ogata et al. Nov 2012 A1
20120302935 Miller Nov 2012 A1
20130041306 Faul et al. Feb 2013 A1
20130056876 Harvey et al. Mar 2013 A1
20130110105 Vankov May 2013 A1
20130172881 Hill et al. Jul 2013 A1
20130190744 Avram et al. Jul 2013 A1
20130190754 Paul et al. Jul 2013 A1
20130216351 Griffin Aug 2013 A1
20130226170 Seddon et al. Aug 2013 A1
20130261368 Schwartz Oct 2013 A1
20130282000 Parsonage Oct 2013 A1
20130296704 Magnin et al. Nov 2013 A1
20140012251 Himmelstein et al. Jan 2014 A1
20140031674 Newman et al. Jan 2014 A1
20140094791 Hull et al. Apr 2014 A1
20140100557 Bohner et al. Apr 2014 A1
20140100562 Sutermeister et al. Apr 2014 A1
20140107642 Rios Apr 2014 A1
20140166098 Kian et al. Jun 2014 A1
20140188028 Brenneman et al. Jul 2014 A1
20140276335 Pate Sep 2014 A1
20150005759 Welches Jan 2015 A1
20150011909 Holmin et al. Jan 2015 A1
20150018810 Baust et al. Jan 2015 A1
20150057654 Leung et al. Feb 2015 A1
20150057687 Gittard Feb 2015 A1
20150080886 Miller et al. Mar 2015 A1
20150094645 Omar-Pasha Apr 2015 A1
20150112195 Berger et al. Apr 2015 A1
20150126965 Liungman May 2015 A1
20150134055 Spence et al. May 2015 A1
20150141836 Naumann et al. May 2015 A1
20150164573 Delaney Jun 2015 A1
20150196309 Matsubara et al. Jul 2015 A1
20150196356 Kauphusman et al. Jul 2015 A1
20150196360 Grantham et al. Jul 2015 A1
20150201962 Kellerman et al. Jul 2015 A1
20150258308 Pate Sep 2015 A1
20150297259 Matsubara et al. Oct 2015 A1
20150313668 Miller et al. Nov 2015 A1
20150320472 Ghaffari et al. Nov 2015 A1
20160022345 Baust et al. Jan 2016 A1
20160051323 Stigall et al. Feb 2016 A1
20160058452 Brenneman et al. Mar 2016 A1
20160058956 Cohn et al. Mar 2016 A1
20160067449 Misener et al. Mar 2016 A1
20160082234 Schwartz et al. Mar 2016 A1
20160100840 Brenneman et al. Apr 2016 A1
20160128855 Heuser et al. May 2016 A1
20160135881 Katoh et al. May 2016 A1
20160184011 Krishnan Jun 2016 A1
20160206317 Dickinson et al. Jul 2016 A1
20170071627 Kellerman et al. Mar 2017 A1
20170119464 Rios et al. May 2017 A1
20170172679 Doty et al. Jun 2017 A1
20170202603 Cohn et al. Jul 2017 A1
20170202616 Pate et al. Jul 2017 A1
20170232272 Perkins et al. Aug 2017 A1
20170252006 Tsuruno Sep 2017 A1
20180000512 Dickinson et al. Jan 2018 A1
20180083228 Yang et al. Mar 2018 A1
20180116522 Brenneman et al. May 2018 A1
20180206845 Brenneman et al. Jul 2018 A1
20180344396 Miller et al. Dec 2018 A1
20200038103 Pappone et al. Feb 2020 A1
20200061338 Pate Feb 2020 A1
20200178970 Berman et al. Jun 2020 A1
Foreign Referenced Citations (28)
Number Date Country
2883209 Apr 2014 CA
1730123 Feb 2006 CN
101730557 Jun 2010 CN
0923912 Jun 1999 EP
11514269 Dec 1999 JP
3127126 Nov 2006 JP
2009545338 Dec 2009 JP
2014500072 Jan 2014 JP
2168951 Jun 2001 RU
9713463 Apr 1997 WO
9729682 Aug 1997 WO
9956640 Nov 1999 WO
2006105008 Oct 2006 WO
2008010039 Jan 2008 WO
2009005644 Jan 2009 WO
2011100625 Aug 2011 WO
2012068273 May 2012 WO
WO-2013112584 Aug 2013 WO
2014028306 Feb 2014 WO
2014052919 Apr 2014 WO
2015061614 Apr 2015 WO
2015085119 Jun 2015 WO
2015108984 Jul 2015 WO
2016033380 Mar 2016 WO
2016081321 May 2016 WO
2017124059 Jul 2017 WO
2017124060 Jul 2017 WO
2018057095 Mar 2018 WO
Non-Patent Literature Citations (21)
Entry
International Search Report and Written Opinion pertaining to PCT/US2019/034896, mailed May 12, 2020.
Maybury et al., “The Effect of Roll Angle on the Performance of Halbach Arrays,” University of California-San Diego, Center for Magnetic Recording Research (2008), 19 pgs.
Choi, et al., Design of a Halbach Magnet Array Based on Optimization Techniques; IEEE Transactions on Magnetics, vol. 44, No. 10, Oct. 2008, pp. 2361-2366. (Year: 2008).
“Banasik et al. (2011).” “A rare variant route of the ulnar artery does not contraindicate the creation of a fistula in the wrist of a diabetic patient with end-stage renal disease,” “Postepy Hig Med Dosw. 65:654-657.”
Bharat et al. (2012). “A novel technique of vascular anastomosis to prevent juxta-anastomotic stenosis following arteriovenous fistula creation,” J. Vascular Surgery 55(1):274-280.
Bode et al. (2011 ). “Clinical study protocol for the arch project Computational modeling for improvement of outcome after vascular access creation,” J. Vase. Access 12(4):369-376.
Hakim et al., “Ulnar artery-based free forearm flap: Review of Specific anatomic features in 322 cases and related literature,” Heand & Neck, Dec. 2013 (published online:2014), Wiley Online Library.
Davidson, I. et al. (2008). “Duplex Ultrasound Evaluation for Dialysis Access Selection and Maintenance: A Practical Guide,” The Journal of Vascular Access 9(1 ): 1-9.
Gracz, et al. (1977). “Proximal forearm fistula for maintenance hemodialysis,” Kidney International 11 :71-75.
Jennings, WC. et al. (2011). “Primary arteriovenous fistula inflow proximalization for patients at high risk for dialysis access-associated ischemic steal syndrome,” J. Vase. Surgery 54(2):554-558.
Kinnaert, et al. (1971). “Ulnar Arteriovenous Fistula for Maintenance Haemodial Ysis,” British J. Surgery 58(9):641-643.
Morale et al. (2011). “Venae comitantes as a potential vascular resource to create native arteriovenous fistulae,” J. Vase. Access 12(3):211-214.
Shenoy, S. (2009). “Surgical anatomy of upper arm: what is needed for AVF planning,” The Journal of Vascular Access 10:223-232.
Vachharajani, T. (2010). “Atlas of Dialysis Vascular Access,” Wake Forest University School of Medicine, 77 total pages.
Whittaker et al. (2011). “Prevention better than cure. Avoiding steal syndrome with proximal radial or ulnar arteriovenous fistulae” J. Vase. Access 12(4):318-320.
Office Action pertaining to corresponding Japanese Patent Application No. 2018-536423, dated Feb. 12, 2021.
Extended European Search Report pertaining to EP Patent Application No. 17853586.0, dated Apr. 29, 2020.
Extended European Search Report for EP Application No. 17739123.2.
Office Action dated Jun. 4, 2021, pertaining to Japanese Patent Application No. 2019-516190.
Office Action dated Dec. 23, 2022, pertaining to Chinese Patent Application No. 201780017044.7.
Office Action, dated Feb. 9, 2023, pertaining to Brazil Patent Application No. BR112018014010-4.
Related Publications (1)
Number Date Country
20190133678 A1 May 2019 US
Provisional Applications (1)
Number Date Country
62279642 Jan 2016 US
Continuations (1)
Number Date Country
Parent PCT/US2017/013611 Jan 2017 WO
Child 16024241 US